Transplant-ineligible newly diagnosed multiple myeloma: current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper

Multiple myeloma is the second most common hematological malignancy in the USA and Europe. Despite improvements in the 5-year and overall survival rates over the past decade, older adults (aged ≥ 65 years) with multiple myeloma continue to experience disproportionately worse outcomes than their youn...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Geriatr Oncol
Autores principales: Grant, Shakira J., Mian, Hira S., Giri, Smith, Boutin, Melina, Dottorini, Lorenzo, Neuendorff, Nina R., Krok-Schoen, Jessica L., Nikita, Nikita, Rosko, Ashley E., Wildes, Tanya M., Zweegman, Sonja
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8113071/
https://ncbi.nlm.nih.gov/pubmed/33342724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2020.12.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares